Institutes
August 10, 2021
UAMS Research Sheds Light on Vaccine Hesitancy in Arkansas
Researchers at UAMS have found that trust in vaccines, fear of infection, and race or ethnicity play a large role in whether or not people will get a COVID-19 vaccine, particularly when looking at socio-demographic factors.
Samer Al Hadidi, M.D., Joins the UAMS Myeloma Center
LITTLE ROCK — Samer Al Hadidi, M.D., has joined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where he will treat patients with myeloma and other plasma cell disorders. “I’m very happy to welcome Dr. Al Hadidi to our staff,” said Frits van Rhee,…
August 9, 2021
UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients
The Myeloma Center at the UAMS Winthrop P. Rockefeller Cancer Institute is offering a new cutting-edge immunotherapy treatment for myeloma patients. The University of Arkansas for Medical Sciences (UAMS) is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.
July 29, 2021
Forbes Magazine Ranks UAMS in Top 30% of Best Employers for Women
Forbes magazine has named the University of Arkansas for Medical Sciences to its list of Best Employers for Women 2021. UAMS was ranked 86th on a list of the top 300 companies in the United States, putting it in the top 30%. UAMS was the only company in Arkansas to make the list. The 300…
July 23, 2021
Grateful Patient Honors UAMS Opthalmologist with $162,000 Gift to Harvey & Bernice Jones Eye Institute
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received a $162,000 commitment from Karen and Roy Burks in honor of John Shock, M.D., to support research at the Harvey & Bernice Jones Eye Institute. “Patient care from Dr. John Shock as well as other faculty at the Jones Eye Institute has…
July 22, 2021
UAMS Performs First GammaTile Brain Surgery in Arkansas
LITTLE ROCK — Radiation oncologist Richard Crownover, M.D., Ph.D., and neurosurgeon Analiz Rodriguez, M.D., Ph.D., and their care team at the University of Arkansas for Medical Sciences (UAMS) have performed the state’s first application of GammaTile Therapy.
July 21, 2021
Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team
LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…
July 20, 2021
UAMS Releases Findings from Statewide COVID-19 Antibody Study
LITTLE ROCK — A statewide COVID-19 antibody study led by UAMS found that by the end of 2020, 7.4% of Arkansans had antibodies to the virus, but there were wide disparities among racial and ethnic groups. UAMS researchers released their findings this week to a public database, medRxiv (med archive).
July 16, 2021
Michael Birrer, M.D., Ph.D., Invested in Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute
LITTLE ROCK — Michael Birrer, M.D., Ph.D., vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), was invested July 15 in the Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute. “Michael Birrer’s scholarly corpus is incredibly impressive, and the…
Blue & You Foundation for a Healthier Arkansas Awards Grants Totaling $1.95 Million for UAMS K-12 Behavioral Health Programs
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received grants totaling $1.95 million from the Blue & You Foundation for a Healthier Arkansas to support two key behavioral health programs. Arkansas Blue Cross and Blue Shield, the largest health insurer in Arkansas, established the Blue & You Foundation for a Healthier…
Previous page Next page